James O'Brien

17 papers receiving 466 citations

Peers

James O'Brien
Comparison fields: 5 of 58
  • Virology 58
  • Epidemiology 208
  • Microbiology 29
  • Immunology 85
  • Infectious Diseases 41
Replace Mary Rinki with:
Mary Rinki United States
Jasneet Aneja United States
Eszter Újhelyi Hungary
Yoann Crabol France
Hoang M. Phan United States
João Borges‐Costa Portugal
Zahava Smetana Israel
L. Ross Whybin Australia
Vani Sundaraiyer United States
E. N. Janoff United States
James O'Brien relative to Mary Rinki United States Mary Rinki's profile →
Citations per field
00.5×2×3.1×
Mary Rinki · 1×
Citations per year

Countries citing papers authored by James O'Brien

Since Specialization
Citations

This map shows the geographic impact of James O'Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James O'Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James O'Brien more than expected).

Fields of papers citing papers by James O'Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James O'Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James O'Brien. The network helps show where James O'Brien may publish in the future.

Co-authors

The 25 scholars most cited alongside James O'Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James O'Brien Line = papers co-authored together James O'Brien links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 1993109
2 200068
3 199561
4
Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
198856
5 201741
6 199737
7 199431
8
Guideline for the management of chronic obstructive pulmonary disease--2011 update.
201128
9 202324
10 199918
11 19879
12 20167
13 19985
14 20235
15 19874
16
Effector characteristics of the IgG3 murine monoclonal antibody 113F1.
19894
17 20222
18 20250

About James O'Brien

James O'Brien is a scholar working on Microbiology, Virology, Immunology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 509 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), HIV Research and Treatment (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immunotherapy and Immune Responses (2 papers), Microbial infections and disease research (2 papers), Transplantation: Methods and Outcomes (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Virology (58 citations), Epidemiology (208 citations), Microbiology (29 citations), Immunology (85 citations) and Infectious Diseases (41 citations). James O'Brien has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Edward N. Janoff, Gordon Meiklejohn, Josephine M. Ehret, Jacinta Mary Douglas, Peter Johann Weiß, Kristin L. Nichol, Paul J. Carson, Mark R. Wallace, Edward C. Oldfield and L M Weiner. Their work appears in journals such as The Journal of Infectious Diseases, Annals of the American Thoracic Society, The Journal of Pediatrics, American Journal of Respiratory and Critical Care Medicine and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact